WINDLAS BIOTECH
|
The Current P/S Ratio of WINDLAS BIOTECH is 2.73.
Share Price | ₹988.8 | Jul 28,2025 |
Market Cap | ₹2,076.5 Cr | |
Sales-TTM | ₹759.9 Cr | TTM-Consolidated Results |
Price/Sales | 2.73x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of WINDLAS BIOTECH
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹2,076.5 Cr] as on Jul 28,2025
(/) Sales [ ₹759.9 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.73x ]
Thus, for WINDLAS BIOTECH , the investors are currently willing to pay '2.73 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of WINDLAS BIOTECH !
The chart below summarizes the trend in P/S Ratio of WINDLAS BIOTECH over the last five years.
Historical PS (Price/Sales) ratio chart of WINDLAS BIOTECH
PS Ratio Performance Analysis for WINDLAS BIOTECH
- WINDLAS BIOTECH 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.29x.
- WINDLAS BIOTECH 's operated at median p/e ratio of 0.98x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WINDLAS BIOTECH 's p/e ratio peaked in Mar2025 at 2.87x.
- WINDLAS BIOTECH 's p/e ratio hit its five-year low in Mar2021 of 0x.
How does WINDLAS BIOTECH 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
WINDLAS BIOTECH | 759.9 | 2.73 | 2,076.5 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 52,578.4 | 7.77 | 408,595.0 |
DIVIS LABORATORIES LTD | 9,360.0 | 18.66 | 174,635.0 |
CIPLA LTD | 27,811.2 | 4.56 | 126,894.0 |
TORRENT PHARMACEUTICALS LTD | 11,835.0 | 10.37 | 122,685.0 |
DR REDDYS LABORATORIES LTD | 33,519.9 | 3.20 | 107,373.0 |
MANKIND PHARMA LTD | 12,279.3 | 8.54 | 104,885.0 |
ZYDUS LIFESCIENCES LTD | 23,241.5 | 4.24 | 98,535.5 |
LUPIN LTD | 22,707.9 | 3.94 | 89,543.0 |
AUROBINDO PHARMA LTD | 31,723.7 | 2.06 | 65,485.4 |
ABBOTT INDIA LTD | 6,409.2 | 10.90 | 69,881.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs WINDLAS BIOTECH 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.06x |
Max industry PS | 18.66x |
Median industry PS | 4.56x |
Average industry PS | 7.00x |
You may also like the below Video Courses